The cyclin-dependent kinase 8 (CDK8) inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4+ T cells via a novel CDK8-GATA3-FOXP3 pathway

Azlann Arnett, Keagan G. Moo, Kaitlin J. Flynn, Thomas B. Sundberg, Liv Johannessen, Alykhan F. Shamji, Nathanael S. Gray, Thomas Decker, Ye Zheng, Vivian H. Gersuk, Ziaur S. Rahman, David E. Levy, Isabelle J. Marié, Peter S. Linsley, Ramnik J. Xavier, Bernard Khor

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The cyclin-dependent kinase 8 (CDK8) inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4<sup>+</sup> T cells via a novel CDK8-GATA3-FOXP3 pathway'. Together they form a unique fingerprint.

Medicine & Life Sciences